Anti-LY6E/ RIG-E/ RIGE monoclonal antibody

Anti-LY6E/ RIG-E/ RIGE antibody for FACS & in-vivo assay

Target products collectionGo to LY6E/LY6E products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0776-Ab-1/ GM-Tg-hg-MP0776-Ab-2Anti-Human LY6E monoclonal antibodyHuman
GM-Tg-rg-MP0776-Ab-1/ GM-Tg-rg-MP0776-Ab-2Anti-Rat LY6E monoclonal antibodyRat
GM-Tg-mg-MP0776-Ab-1/ GM-Tg-mg-MP0776-Ab-2Anti-Mouse LY6E monoclonal antibodyMouse
GM-Tg-cynog-MP0776-Ab-1/ GM-Tg-cynog-MP0776-Ab-2Anti-Cynomolgus/ Rhesus macaque LY6E monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0776-Ab-1/ GM-Tg-felg-MP0776-Ab-2Anti-Feline LY6E monoclonal antibodyFeline
GM-Tg-cang-MP0776-Ab-1/ GM-Tg-cang-MP0776-Ab-2Anti-Canine LY6E monoclonal antibodyCanine
GM-Tg-bovg-MP0776-Ab-1/ GM-Tg-bovg-MP0776-Ab-2Anti-Bovine LY6E monoclonal antibodyBovine
GM-Tg-equg-MP0776-Ab-1/ GM-Tg-equg-MP0776-Ab-2Anti-Equine LY6E monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0776-Ab-1/ GM-Tg-hg-MP0776-Ab-2; GM-Tg-rg-MP0776-Ab-1/ GM-Tg-rg-MP0776-Ab-2;
GM-Tg-mg-MP0776-Ab-1/ GM-Tg-mg-MP0776-Ab-2; GM-Tg-cynog-MP0776-Ab-1/ GM-Tg-cynog-MP0776-Ab-2;
GM-Tg-felg-MP0776-Ab-1/ GM-Tg-felg-MP0776-Ab-2; GM-Tg-cang-MP0776-Ab-1/ GM-Tg-cang-MP0776-Ab-2;
GM-Tg-bovg-MP0776-Ab-1/ GM-Tg-bovg-MP0776-Ab-2; GM-Tg-equg-MP0776-Ab-1/ GM-Tg-equg-MP0776-Ab-2
Products NameAnti-LY6E monoclonal antibody
Formatmab
Target NameLY6E
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-LY6E benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species LY6E/ RIG-E/ RIGE VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP000777human LY6E Lentivirus particle
    ORF Viral VectorpGMLP000777human LY6E Lentivirus plasmid
    ORF Viral VectorpGMLPm000550mouse Ly6e Lentivirus plasmid
    ORF Viral VectorvGMLPm000550mouse Ly6e Lentivirus particle


    Target information

    Target IDGM-MP0776
    Target NameLY6E
    Gene ID4061,17069,362934,114680363,100683006,101098195,510977,100066193
    Gene Symbol and SynonymsLy67,LY6E,RIG-E,RIGE,SCA-2,SCA2,TSA-1,Tsa1
    Uniprot AccessionQ16553
    Uniprot Entry NameLY6E_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000160932
    Target ClassificationN/A

    The target: LY6E, gene name: LY6E, also named as RIG-E, RIGE, SCA-2, SCA2, TSA-1. This gene belongs to the human Ly6 gene family and encodes a glycosylphosphatidyl-inositol (GPI)-anchored cell surface protein. The protein plays an important role in T cell physiology, oncogenesis and immunological regulation. The protein is also involved in modulation of viral infection by coronaviruses, SARS-CoV, MERS-CoV and SARS-CoV-2. [provided by RefSeq, Aug 2021].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.